The announcement was made at the inaugural meeting of the Biopharmaceutical Alliance, held in San Diego, California, during the Bio International Convention 2024, the world’s largest biopharmaceutical exhibition.

Government officials and representatives from bio and pharmaceutical companies from the participating countries attended the meeting.

The participants emphasised the importance of a reliable and sustainable supply chain and agreed to coordinate the respective countries’ bio policies, regulations, and research and development support measures.

They recognised the production of essential raw materials and ingredients is concentrated in a few countries and agreed to work together to build a detailed pharmaceutical supply chain map.

The alliance was launched in response to the drug supply shortages experienced during the Covid-19 pandemic.